OpenAlex
PricingAboutJobs
Log inGet started
Work

Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States

HTML

Year: 2015
Type: article
Source: Clinical and Applied Thrombosis/Hemostasis
DOI: 10.1177/1076029615585991
Authors: Alpesh Amin, Amanda Bruno, Jeffrey Trocio, Jay Lin, Melissa Lingohr-Smith
Institutions: University of California, Irvine, Bristol-Myers Squibb (United States), Pfizer (United States)
Language: English

Topic: Venous Thromboembolism Diagnosis and Management
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Keywords: direct oral anticoagulants, warfarin, venous thromboembolism, apixaban, rivaroxaban, edoxaban, dabigatran, major bleeding, recurrent venous thromboembolism, payer perspective
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1847190482
FWCI: 4.866
Cites: 17
Cited by: 25
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security